ADVFN - Advanced Financial Network.
HOME» NYSE » R » RMD Stock Price » RMD Stock News

Resmed Share News

 Resmed Inc. Stock Price
RMD Stock Price
 Resmed Inc. Stock Chart
RMD Stock Chart
 Resmed Inc. Stock News
RMD Stock News
 Resmed Inc. Company Information
RMD Company Information
 Resmed Inc. Stock Trades
RMD Stock Trades

Australia ACCC: ResMed Accepts Undertaking On Retail Price Maintenance

SYDNEY -(Dow Jones)- Sleep disorder device company ResMed Inc. (RMD.AU) has agreed to revise its internal fair-trading checks following an investigation of price-fixing by Australia's competition regulator. The Australian Competition and Consumer Commission said Tuesday it had investigated the company over whether it was telling accredited retailers that it would stop supplying its products if they sold them at less than a price specified by ResMed, a practice known as retail price maintenance. "The ACCC is concerned that between March and June 2009 ResMed is likely to have engaged in retail price maintenance," the ACCC said in a statement. ResMed has accepted a court-enforceable undertaking to write to its accredited retailers telling them they are free to set their own prices, and to amend its compliance program for Australian trade practices law, the ACCC said. ResMed did not immediately respond to a call for comment. -By David Fickling, Dow Jones Newswires; +61 2 8272 4689; david.fickling@dowjones.com

Stock News for Resmed (RMD)
DateTimeHeadline
05/27/201517:09:39Specialized Disclosure Report (sd)
05/19/201519:35:18Statement of Changes in Beneficial Ownership (4)
05/13/201515:54:07Why ResMed's Stock Is in the Red Today
05/13/201512:19:19Why ResMed's Stock Is in the Red Today
05/13/201506:09:20Current Report Filing (8-k)
05/13/201503:55:00ResMed publie un état des lieux de l'étude SERVE-HF de phase I...
05/13/201503:00:00ResMed Provides Update on Phase III SERVE-HF Study of Adaptive...
05/13/201503:00:00ResMed Provides Update on Phase III SERVE-HF Study of Adaptive...
05/13/201503:00:00ResMed Provides Update on Phase III SERVE-HF Study of Adaptive...
05/05/201522:00:00Oceania & ASEAN Respiratory Market to Boost APAC Region Owing...
05/05/201522:00:00Oceania & ASEAN Respiratory Market to Boost APAC Region Owing...
05/05/201517:55:31Statement of Changes in Beneficial Ownership (4)
04/30/201509:00:00ResMed Introduces Lumis Series of Noninvasive Ventilators for...
04/29/201506:09:37Quarterly Report (10-q)
04/27/201504:19:26Goldman Sachs Downgrades ResMed to Neutral (RMD)
04/26/201503:53:59ResMed Stock Rating Reaffirmed by Canaccord Genuity (RMD)
04/24/201513:39:07Why ResMed Inc. Shares Are Getting Clobbered
04/24/201510:37:58ResMed Price Target Increased to $66.00 by Analysts at BMO Capital...
04/24/201507:43:56Macquarie Lowers ResMed to Neutral (RMD)
04/23/201516:07:08Current Report Filing (8-k)

Resmed and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad